Who will bid....no idea...the question and only question is what will they do with the patent. Do they continue with costly and lengthy pharmaceutical indications that very few (if any) on this board will see come to market? Or, will they recognize the changing political winds and reintroduce Anatabloc to a friendly FDA as an anti inflammatory that served 10's of thousands.